The Corporate Press Release Ledger tracks 8-K Regulation FD and Item 7.01 and 8.01 press-release filings with extracted exhibit titles, detected wire services and topic families, drawn from public SEC EDGAR data over a rolling window and refreshed daily. Every entry links the official filing; topics are derived labels, not issuer claims.
Yarrow Bioscience Announces Closing of Merger with VYNE Therapeutics and Initiation of Dosing in Phase 2a/2b Trial of YB-101, a Potential First-in-Class Treatment for Graves’ Disease and Thyroid Eye D